Have your own idea? Try our Stock Screener
UPDATED Nov 29, 2024
Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BGNE | US$215.00 | 12.9% | 14.7% | US$22.8b | US$280.06 | PS7x | E73.2% | n/a | ||
NTRA | US$167.78 | 0.3% | 187.0% | US$22.2b | US$163.45 | PS14.5x | E69.4% | n/a | ||
TEVA | US$16.78 | -2.0% | 72.8% | US$19.0b | US$22.36 | PS1.1x | E65.8% | 0% | ||
ICLR | US$210.25 | -1.9% | -21.9% | US$17.4b | US$276.06 | PE23.2x | E13.4% | n/a | ||
MRNA | US$43.06 | 4.7% | -46.1% | US$16.6b | US$76.36 | PS3.3x | E17.1% | n/a | ||
UTHR | US$370.49 | -0.6% | 53.9% | US$16.5b | US$382.22 | PE14.9x | E8.1% | n/a | ||
RPRX | US$26.66 | 0.9% | -2.5% | US$15.7b | US$41.53 | PE10.3x | E6.3% | 3.2% | ||
VTRS | US$13.09 | -2.1% | 39.7% | US$15.6b | US$13.33 | PS1x | E51.6% | 3.7% | ||
INCY | US$74.59 | 4.0% | 38.1% | US$14.4b | US$78.31 | PE442.4x | E46.5% | n/a | ||
AVTR | US$21.06 | 1.3% | -1.5% | US$14.3b | US$27.31 | PE46.3x | E36.4% | n/a | ||
RVTY | US$116.14 | 3.7% | 27.2% | US$14.1b | US$138.68 | PE54.7x | E19.9% | 0.2% | ||
SMMT | US$18.46 | -2.8% | 766.7% | US$13.6b | US$34.27 | PB31.1x | S85.4% | n/a | ||
INSM | US$75.16 | 2.7% | 183.4% | US$13.4b | US$89.40 | PS39.2x | E54.4% | n/a | ||
NBIX | US$126.75 | 0.9% | 8.2% | US$12.8b | US$163.46 | PE33.3x | E29.6% | n/a | ||
SRPT | US$133.34 | 16.7% | 57.9% | US$12.7b | US$183.82 | PE104.5x | E42.5% | n/a | ||
BMRN | US$66.03 | 2.8% | -28.6% | US$12.6b | US$98.02 | PE39x | E27.2% | n/a | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
TECH | US$75.36 | 5.7% | 16.7% | US$12.0b | US$85.25 | PE79.5x | E21.2% | 0.4% | ||
PCVX | US$94.34 | 6.6% | 75.3% | US$11.8b | US$151.75 | PB3.4x | E-4.5% | n/a | ||
EXAS | US$62.08 | 17.3% | -7.4% | US$11.5b | US$70.81 | PS4.3x | E72.4% | n/a | ||
CTLT | US$61.11 | 0.2% | 52.2% | US$11.1b | US$63.43 | PS2.5x | E74.5% | n/a | ||
MEDP | US$340.63 | 0.9% | 23.7% | US$10.6b | US$347.92 | PE28.9x | E10.7% | n/a | ||
EXEL | US$36.46 | 2.4% | 66.2% | US$10.4b | US$31.83 | PE22.3x | E15.6% | n/a | ||
CRL | US$199.06 | 1.7% | -1.3% | US$10.2b | US$216.27 | PE24.6x | E12.4% | n/a |